ClinicalTrials.gg
RecruitingNCT05992272ReCoDeUpdated Aug 21, 2024

Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer

An observational study in Alcohol Use Disorder (AUD), Alcoholism and Substance Use Disorders, sponsored by Charite University, Berlin, Germany. Recruiting at 2 sites in Germany. Open to participants aged 16 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-08-21.

Sponsored by Charite University, Berlin, Germany · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Nov 2020; still recruiting 5 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
300
Ages
16 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Alcoholism by Charite University, Berlin, Germany — 4 open to participants now, 4 under way, none of them phase 3. Alcoholism · Charite University, Berlin, Germany.

Started
2020
the only one that year
Observational
7 of 14
1 open now
Registered
9th of 14
by date

Among the 14 studies in Alcoholism by Charite University, Berlin, Germany, this one is the only one that started in 2020, is one of 7 observational ones, and was the 9th registered.

Alcoholism

1,679 studies on the registry are indexed under Alcoholism; 333 are open to participants now.

Browse Alcoholism studies →

Open to participants now

4 of the 14 studies in Alcoholism by Charite University, Berlin, Germany are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 238 Alcoholism studies recruiting now, 85 (36%) set no upper age limit and 131 (55%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.

This study: 16 Years to 65 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Alcoholism by Charite University, Berlin, Germany, or all of them as a file.
02

Study summary

Individuals with substance use disorders (SUD) have to cope with drug-related cues and contexts, which can affect instrumental drug seeking as shown with Pavlovian to instrumental transfer (PIT) paradigms in animals and humans. The investigators aimed to investigate the impact of acute and chronic stress on Pavlovian-to-instrumental transfer (PIT), how PIT it is associated with cognitive control abilities and whether such effects predict losing vs. regaining control in subjects with AUD. Moreover, the investigators aimed to develop a novel full transfer task that assesses both, general and specific PIT to investigate whether specific PIT differs between alcohol use disorder (AUD) and control subjects.

Read the detailed description

This project has four research aims:

  1. The investigators want to assess the effects of acute as well as repeated stress exposure on PIT and its neuroimaging correlates, and the investigators will test whether modulation of PIT by stress predicts losing vs. regaining control of drug intake in mild to moderate AUD subjects.
  2. The investigators will investigate how cognitive control abilities (e.g. interference control and response inhibition) are related to the costs of interference between Pavlovian and instrumental control in PIT.
  3. The investigators will compare PIT, its relation to cognitive control, and the neural mechanisms between different drugs of abuse by investigating participants with AUD and also smokers.
  4. The investigators will develop an outcome-specific PIT paradigm with alternative (food) and drug rewards to compare AUD and healthy controls, and the investigators will explore communalities and differences in behavioral and neural processes between general PIT and outcome-specific PIT.

Therefore, the investigators conduct 3 Experiments with the following Hypotheses:

Experiment 1:

Here the investigators assess on a behavioral and neural level a general PIT task that consists of four parts:

In the instrumental part, participants have to learn which shells to collect or leave in order to gain as much money as possible; the correct choice is probabilistically rewarded in 80% of all times. Absolutely unrelated to this instrumental part, during Pavlovian conditioning colorful fractals are presented in the back of the screen, which have been passively paired either with monetary gain, no change or monetary loss, i.e. they act as positively valued, neutral or negatively valued cues. These fractals thus act as independent, Pavlovian conditioned background stimuli and interact with instrumental behavior in the unrelated third transfer part of the PIT task. Also, the investigators assess the effects of drug-specific cues in the background on instrumental behavior during this transfer part. To avoid further learning, the transfer part will be conducted under nominal extinction. Finally, query trials, in which participants will have to choose one of two pictures will to assess the relative cue value.

Acute stress will be induced by the Trier Social Stress Test (TSST), chronic stress will be assessed by questionnaires and hair cortisol.

Hypothesis 1a:

Acute and chronic stress exposure increase behavioral and neural PIT effects elicited by monetary Pavlovian conditioned stimuli (CS) and decrease inhibitory effects of alcohol Pavlovian CS. Functional correlates of PIT effects will be found in the amygdala and in the ventral striatum.

Hypothesis 1b:

Following stress exposure, high PIT effects elicited by monetary Pavlovian CS and low inhibitory effects elicited by alcohol Pavlovian CS predict higher subsequent alcohol intake in the follow-up period of 6 months.

Methods:

Between group analysis: The investigators will analyze on a behavioral and imaging level how acutely consuming AUD subjects and matched controls differ regarding money- and alcohol-related PIT.

Within-group analysis: The investigators will analyze how acute stress affects PIT effects. This 2x2 design (1 within-group subject factor with two levels: STRESS vs. NO STRESS and 1 between-group subject factor with two levels: AUD vs. matched controls) will be tested on a behavioral and neural level.

Experiment 2:

In this experiment, the investigators will utilize a 2x3 factorial group design. Participants will be categorized into two main groups: those with AUD and those without (non-AUD). Each of these groups will be further divided into three subgroups: daily smokers, non-daily smokers and non-smokers. Each cell (individual subgroup) will consist of 35 subjects. In addition to the PIT task described above, the N = 210 participants will additionally perform a Counting Stroop task and a No-go Simon task. Participants will also perform a stop signal task during functional MRI (fMRI).

Methods:

Interference Costs: Interference costs will be calculated based on error rate (ER) and reaction time (RT) differences between task conditions, e.g., incongruent vs. congruent conditions.

Between-group analysis: the investigators will examine group differences in the interference PIT effect at both the behavioral and neural levels using a two (AUD vs. non-AUD) by three (daily smokers vs. non-daily smokers vs. non-smokers) design. In addition, the investigators aim to investigate the associations between the interference PIT effect and other continuous measures: Alcohol Use Disorders Identification Test (AUDIT), Fagerström Test for Nicotine Dependence (FTND), along with quantity-frequency indices.

Other analysis: In order to gain a better understanding of the mechanisms underlying PIT, the investigators will also fit a drift diffusion model to the behavioral data and explore the connectivity within the neural networks during PIT in relation to the connectivity during the stop signal task (response inhibition).

Hypothesis 2a:

Interference costs (i.e. increased error rate [ER] in instrumental responses) during PIT are associated with interference costs at the stimulus level (Stroop task) and at the response level (No-go Simon task), and these costs will also be correlated with the ER during response inhibition (No-go Simon task).

Hypothesis 2b:

The investigators hypothesize that the interference PIT effect will be more pronounced in the AUD group compared to the non-AUD group. The investigators also anticipate that the effect will be stronger in the smoker group. Furthermore, the investigators hypothesize a positive correlation between the PIT effect and AUDIT, FTND scores, as well as the quantity and frequency of use. As the behavioral PIT effect intensifies, the investigators expect corresponding neural responses to similarly increase.

Experiment 3:

The investigators here use a newly-developed full PIT paradigm that introduces primary reinforcers, i.e. alcoholic and soft drinks (that the investigators administer on a trial-by-trial basis). Furthermore, the investigators implemented additional Pavlovian stimuli to examine both general and outcome-specific PIT effects. General PIT effects occur when positively valued environmental Pavlovian stimuli enhance instrumental responding regardless of the reinforcer being used. Here, stimuli that are associated with e.g. monetary rewards can enhance instrumental responding for alcohol drinks, demonstrating a general motivational effect. In contrast, during outcome-specific PIT, this effect is limited for the same stimulus-reward association. For instance, Pavlovian stimuli associated with a soft drink promote choices for the same soft drink outcome only.

Methods:

Between-group Analysis: The investigators will assess the outcome-specific PIT effects by measuring the change in the proportion of alcohol choices when the alcohol cue is presented versus when the soft drink (juice) cue is shown. On the other hand, the investigators will define general PIT effects as the increase in button presses (i.e., slope) corresponding to the increased valence of the conditioned monetary cues. The investigators plan to examine the differences in both specific and general PIT effects at both the behavioral and neural levels between the AUD group and the non-AUD group, controlling for smoking status. Additionally, the investigators will investigate the relationship between specific and general PIT effects and AUDIT, along with quantity-frequency measures Comparison between the two PIT tasks: the investigators will explore similarities and differences in PIT effects between the full PIT paradigm and the previously-mentioned single-lever PIT paradigm.

Stress: the investigators will test whether levels of chronic stress (assessed with questionnaires and hair cortisol as for Experiment 1) moderate outcome-specific and full PIT effects.

Hypothesis 3a:

The investigators expect that both outcome-specific and general PIT effects will be stronger in participants with AUD compared to those without AUD, evident at both behavioral and neural levels. Additionally, the investigators predict positive associations between PIT effects and both AUDIT scores and quantity-frequency measures.

Hypothesis 3b:

the investigators hypothesize that the PIT effect found in the single-lever PIT task is more strongly associated with the general PIT and less strongly associated with the outcome-specific PIT effect in the full PIT task.

Hypothesis 3c:

Increased chronic stress will enhance effects of both general and outcome-specific PIT.

03

Conditions studied

  • Alcohol Use Disorder (AUD)
  • Alcoholism
  • Substance Use Disorders
  • Smoking, Tobacco
  • Stress Reaction
  • Stress

Keywords

  • substance use disorder (SUD), cognitive control/interference
  • alcohol use disorder (AUD)
  • Smokers
  • general and outcome-specific Pavlovian to instrumental transfer
  • chronic and acute stress
  • Amygdala
  • Stroop Test
  • Ventral Striatum
  • Neuroimaging
  • Humans
  • Surveys and Questionnaires
  • Reward
  • Fractals
  • Cues
04

Who can participate

Ages eligible
16 Years to 65 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

All groups will be recruited from general population via advertisement (e.g. ebay Kleinanzeigen, Facebook) and notes (e.g. blackbords, intranet) in Berlin and Dresden

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • males and females between 16-65 years of age
  • AUD subjects only: meet a minimum of 2 criteria for alcohol-related disorder (AUD) (not requiring withdrawal as assessed by an independent psychiatrist) and AUDIT > 4
  • Smokers: Daily smokers only: smoke 7 days/week during the last three months
  • Non-daily smokers only: smoke at least once but less than 7 days/week during the last three months
  • Ability to consent to the study and complete the questionnaires
  • Sufficient language skills: German
  • Availability between 3pm-6pm on 2 consecutive days (Experiment 1, acute stress question)
  • Females only: luteal phase (Experiment 1, acute stress question)

Exclusion criteria

Exclusion Criteria:

  • Lifetime diagnosis according to DMS-5 for: Bipolar disorder, schizophrenia, schizophrenia spectrum disorder, substance dependence except for alcohol, nicotine, or cannabis
  • Currently meeting diagnostic criteria for a depressive episode, suicidal ideation
  • Past traumatic brain injury or severe neurological disease (such as dementia, Parkinson's disease, multiple sclerosis)
  • Pregnancy or breastfeeding
  • Ingestion of medications known to interact with the CNS in the 10-day period prior to study participation or less than 4 half-lives after last ingestion (rapid urine test)
  • MR (e.g., pacemakers, metallic or electronic implants, metallic splinters, surgical staples)
  • Color vision deficiency
  • Sensorineural hearing loss of 30 dB or greater,
  • Tinnitus
  • Presence of claustrophobia
  • Acute alcohol intoxication at MRI appointments verified by breath alcohol testing or drug intoxication verified by rapid urine testing
  • For women only: not peri- or , not taking (Experiment 1, acute stress question)
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • alcohol use disorder (AUD)

    Participants with alcohol use disorder (mild to moderate or severe if no withdrawal symptoms) including: * daily smokers (at least 1 cigarette per day in last 3 months) * non-daily (min 1x/last 3months) * non-smokers

    Biological: fMRI imaging (BOLD) · Biological: sMRI (structure) · Behavioral: Trier Social Stress Test · Behavioral: PIT paradigm · Behavioral: Counting Stroop task · Behavioral: No-go Simon task · Diagnostic Test: Stop Signal Task · Diagnostic Test: blood samples · Diagnostic Test: questionnaires for chronic stress · Diagnostic Test: hair samples · Diagnostic Test: saliva samples · Diagnostic Test: EMA assessment · Diagnostic Test: clinical diagnostic

  • non-AUD

    Participants with a maximum of 1 AUD criteria according to DSM-5, including: * daily smokers (at least 1 cigarette per day in last 3 months) * non-daily (min 1x/last 3months) * non-smokers

    Biological: fMRI imaging (BOLD) · Biological: sMRI (structure) · Behavioral: Trier Social Stress Test · Behavioral: PIT paradigm · Behavioral: Counting Stroop task · Behavioral: No-go Simon task · Diagnostic Test: Stop Signal Task · Diagnostic Test: blood samples · Diagnostic Test: questionnaires for chronic stress · Diagnostic Test: hair samples · Diagnostic Test: saliva samples · Diagnostic Test: clinical diagnostic

Interventions

  • BiologicalfMRI imaging (BOLD)

    Will be used to investigate neural correlates of PIT effects by measuring the blood oxygenation level dependent (BOLD) response of neural activation in the mesolimbic system.

  • BiologicalsMRI (structure)

    Will be used to investigate neural correlates of PIT effects by identifying abnormalities in cortical gray and white matter volume.

  • BehavioralTrier Social Stress Test

    Will be used to assess the effect of acute stress induction on behavioral and neural PIT effects. The induced stress is generated in a social context, where the participants are asked to prepare a job interview for their dream job and to present it in front of a three-member jury.

  • BehavioralPIT paradigm

    The paradigm consists of four parts: In the first part, an instrumental learning task is completed in which subjects must learn which stimuli require a response and which do not. In the second part, a classical (Pavlovian) conditioning task is then completed in which subjects learn by passive viewing which stimuli are associated with certain amounts of money. The third part measures to which instrumental responses (learned in Part 1) are modulated by the presentation of the classically conditioned stimuli (learned in Part 2). At the same time drug-associated stimuli are presented in the background measuring to which extent they conflict with the learned instrumental behavior. In the last part, query trials are implemented in which the participants have to choose between two pictures to assess the relative cue value.

  • BehavioralCounting Stroop task

    Will be used to assess interference at stimulus level. Here either one, two, three or four identical digits from 1 to 4 are shown. Number and denotation of digits are either congruent (1, 22, 333, 4444; 88 trials) or incongruent (111, 2222, 3, 4444; 88 trials). Subjects have to indicate how many digits were shown

  • BehavioralNo-go Simon task

    Will be used to measure interference at the response level and response inhibition. We will show arrows either pointing to the left or right. The arrow can either be shown on the left or the right side of the display. In congruent trials, direction and position are the same, whereas they differ in incongruent trials. Participants have to indicate the direction of the arrow and ignore the position.

  • Diagnostic testStop Signal Task

    Will be used to examine inhibitory control. The participants tap the left and right side of the screen to smash two falling fruits. When the fruits pass two circles, subjects are required to tap both sides of the screen. In "stop trials" one of the fruits turns brown (rotten), indicating the corresponding side of the screen should not be tapped.

  • Diagnostic testblood samples

    for genetic and epigenetic testing, especially for exploratory outcome prediction using polygenic risk scores.

  • Diagnostic testquestionnaires for chronic stress

    * Perceived Stress Scale * Social Readjustment Rating Scale * Trier Inventory for the Assessment of Chronic

  • Diagnostic testhair samples

    Hair cortisol measurement (3 cm hair segments) will be used to assess chronic stress.

  • Diagnostic testsaliva samples

    Assessing acute stress effects in AUD.

  • Diagnostic testEMA assessment

    We will use smartphones with additional mobile sensors (wearables), which will be used to measure physical activity, data on location (GPS), geolocation-based triggering of e-Diaries, self-reported stress reactivity, cue exposure (encounters with drug-related stimuli in real life), drug craving, impulsivity and drug consumption (priming doses, binges and continuous use of all drugs of abuse).

  • Diagnostic testclinical diagnostic

    SKID-I Interview neurocognitive and psychopathological testing

06

What researchers measure

Primary outcomes

  1. Neural PIT effect day 1

    blood oxygenation level dependent (BOLD) response, investigation of neuronal activation of the mesolimbic system in AUD patients and controls using 3 Tesla magnetic resonance imaging following Stress or Placebo intervention OR no intervention

    Time frame: Day 1

  2. Neural PIT effect day 2

    a subsample of subjects has a second assessment with blood oxygenation level dependent (BOLD) response, investigation of neuronal activation of the mesolimbic system in AUD patients and controls using 3 Tesla magnetic resonance imaging following Stress or Placebo intervention

    Time frame: Day 2

  3. Behavioral PIT effect on performance day 1

    strength of PIT effect assessed with the PIT paradigm. Performance (correct choices) will be recorded. Stronger PIT effects are associated with higher performance (percent correct choices) in congruent versus lower performance in incongruent trials.

    Time frame: Day 1

  4. Behavioral PIT effect on velocity day 1

    strength of PIT effect assessed with the PIT paradigm. Velocity will be recorded. Stronger PIT effects are associated with higher velocity in conditions with positively valued background stimuli and lower velocity with negatively valued background stimuli.

    Time frame: Day 1

  5. Behavioral PIT effect on velocity day 2

    a subsample of subjects has a second assessment with the PIT paradigm (parallel version) following Stress or Placebo intervention. At this second day the investigators calculate velocity PIT effect only.

    Time frame: Day 2

  6. Chronic stress effects on hair cortisol in picogram/milligram

    chronic stress assessment via: - hair cortisol measurement (3 cm hair segments)

    Time frame: retrospective assessment before PIT testing at Day 1

  7. Chronic stress quenstionnaire 1

    chronic stress assessment via: - Trier Inventory for the Assessment of Chronic Stress (TICS; assessing chronic stress over the last three months, likert scale 0-4, with zero meaning never and four meaning very often; high values stand for more stress))

    Time frame: retrospective assessment before PIT testing at Day 1

  8. Chronic stress quenstionnaire 2

    chronic stress assessment via: - Social Readjustment Rating Scale (SRRS; assessing chronic stress life events of the last year, scaling asking for yes or no. higher values represent more stressful live events over the last year)

    Time frame: retrospective assessment before PIT testing at Day 1

  9. Chronic stress quenstionnaire 3

    chronic stress assessment via: - Perceived Stress Scale (PSS; assessing chronic stress over the last month, likert scale 0-4, with zero meaning never and four meaning very often; high values stand for higher perceived stress)

    Time frame: retrospective assessment before PIT testing at Day 1

  10. cognitive control Stroop effect

    Cognitive control assessment via: - Counting Stroop task

    Time frame: Day 1

  11. cognitive control Simon effect

    Cognitive control assessment via: No-go Simon task

    Time frame: Day 1

  12. cognitive control interference effect

    Cognitive control assessment via: Stop Signal reaction time task

    Time frame: Day 1

  13. Acute stress day 1

    Acute stress inducting using: Trier social stress test (TSST) OR placebo (randomized across days between subjects)

    Time frame: Day 1

  14. Acute stress day 2

    Acute stress inducting using: Trier social stress test (TSST) OR placebo (randomized across days between subjects)

    Time frame: Day 2

Secondary outcomes

  1. Saliva cortisol concentration in nmol/litre

    Acute stress effects in AUD and HC

    Time frame: Assessment before, during and after TSST (-60 minutes, 0 minutes, +10 minutes, +20 minutes, +30 minutes,+ 50 minutes, +80 minutes)

  2. alcohol consumption after 12 months

    alcohol drinking amount (quantity, frequency) during a follow-up period of 12 months

    Time frame: 12 months after testing for behavioral and neural PIT effects

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Belanger MJ, Chen H, Hentschel A, Garbusow M, Ebrahimi C, Knorr FG, Zech HG, Pilhatsch M, Heinz A, Smolka MN. Development of Novel Tasks to Assess Outcome-Specific and General Pavlovian-to-Instrumental Transfer in Humans. Neuropsychobiology. 2022;81(5):370-386. doi: 10.1159/000526774. Epub 2022 Nov 14. PubMed 36380640 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2020 (actual). Primary completion is estimated for Dec 2024, 49 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2023
First posted
Aug 15, 2023
StartActual
Nov 24, 2020
Primary completionEst.
Dec 31, 2024
CompletionEst.
Dec 31, 2024
Last update
Aug 21, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05992272
Responsible party
Andreas Heinz (head of Department of Psychiatry and Psychotherapy | CCM, principle investigator, Charite University, Berlin, Germany) — Principal investigator
First posted
Aug 15, 2023
Start date
Nov 24, 2020
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
Aug 21, 2024

Study contacts

Andreas Heinz, Prof., MD, PhD
Contact
andreas.heinz@charite.de
0049 30 450 517 001
Maximilian Pilhatsch, MD, PhD
Contact
max.pilhatsch@uniklinikum-dresden.de
0049 (351) 458 19312

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion